Stryker price target raised to $400 from $360 at Canaccord

Canaccord raised the firm’s price target on Stryker (SYK) to $400 from $360 and keeps a Buy rating on the shares. The firm said they delivered an impressive Q3 of 11.9% reported growth, raising the low end of its top and bottom line guidance while citing continued healthy capital demand and procedure volumes.